DK1235558T3 - Sammenpresset tabletsammensætning, der omfatter et NSAID - Google Patents

Sammenpresset tabletsammensætning, der omfatter et NSAID

Info

Publication number
DK1235558T3
DK1235558T3 DK00990644T DK00990644T DK1235558T3 DK 1235558 T3 DK1235558 T3 DK 1235558T3 DK 00990644 T DK00990644 T DK 00990644T DK 00990644 T DK00990644 T DK 00990644T DK 1235558 T3 DK1235558 T3 DK 1235558T3
Authority
DK
Denmark
Prior art keywords
nsaid
tablet composition
compressed tablet
compressed
composition
Prior art date
Application number
DK00990644T
Other languages
Danish (da)
English (en)
Inventor
Robert Arthur Sherry
Tracey Jane Rhoades
Frederick Raymond Higton
Original Assignee
Reckitt Benckiser Healthcare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9929077.7A external-priority patent/GB9929077D0/en
Priority claimed from GBGB9929078.5A external-priority patent/GB9929078D0/en
Application filed by Reckitt Benckiser Healthcare filed Critical Reckitt Benckiser Healthcare
Application granted granted Critical
Publication of DK1235558T3 publication Critical patent/DK1235558T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK00990644T 1999-12-09 2000-11-30 Sammenpresset tabletsammensætning, der omfatter et NSAID DK1235558T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9929077.7A GB9929077D0 (en) 1999-12-09 1999-12-09 Therapeutic agents
GBGB9929078.5A GB9929078D0 (en) 1999-12-09 1999-12-09 Therapeutic agents

Publications (1)

Publication Number Publication Date
DK1235558T3 true DK1235558T3 (da) 2006-10-09

Family

ID=26316111

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00990644T DK1235558T3 (da) 1999-12-09 2000-11-30 Sammenpresset tabletsammensætning, der omfatter et NSAID

Country Status (27)

Country Link
US (1) US8124124B2 (cs)
EP (1) EP1235558B1 (cs)
JP (1) JP4040878B2 (cs)
KR (1) KR20020082464A (cs)
CN (1) CN100346774C (cs)
AR (1) AR026917A1 (cs)
AT (1) ATE324868T1 (cs)
AU (1) AU776308B2 (cs)
BG (1) BG66007B1 (cs)
BR (1) BR0016236A (cs)
CA (1) CA2393585C (cs)
CY (1) CY1106136T1 (cs)
CZ (1) CZ300558B6 (cs)
DE (1) DE60027761T2 (cs)
DK (1) DK1235558T3 (cs)
ES (1) ES2263510T3 (cs)
HK (1) HK1046644B (cs)
HU (1) HU227045B1 (cs)
IL (2) IL150030A0 (cs)
MX (1) MXPA02005663A (cs)
NO (1) NO332259B1 (cs)
NZ (1) NZ519485A (cs)
PL (1) PL201223B1 (cs)
PT (1) PT1235558E (cs)
RU (1) RU2246294C2 (cs)
SK (1) SK285706B6 (cs)
WO (1) WO2001041733A2 (cs)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0113841D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
GB0113839D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
GB0113843D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
PL373914A1 (en) * 2002-02-01 2005-09-19 Pfizer Products Inc. Immediate release dosage forms containing solid drug dispersions
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
GB0423103D0 (en) * 2004-10-19 2004-11-17 Boots Healthcare Int Ltd Therapeutic agents
EA010751B1 (ru) * 2005-02-03 2008-10-30 Никомед Фарма Ас Гранулирование из расплава композиции, содержащей кальцийсодержащее соединение
DE102005037630A1 (de) 2005-08-09 2007-02-15 Glatt Gmbh Verfahren zur Herstellung von Teilchen aus pharmazeutischen Substanzen, Teilchen aus pharmazeutischen Substanzen sowie deren Verwendung
GB0519350D0 (en) 2005-09-22 2005-11-02 Boots Healthcare Int Ltd Therapeutic agents
CA2633266C (en) * 2005-12-16 2011-08-02 Hanmi Pharm. Co., Ltd. Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same
ATE489077T1 (de) * 2006-09-28 2010-12-15 Losan Pharma Gmbh Schnell lösliche formulierung von nichtsteroidalen antiphlogistika
GB2447898B (en) * 2007-03-24 2011-08-17 Reckitt Benckiser Healthcare A tablet having improved stability with at least two actives
DE102008048729A1 (de) * 2008-09-24 2010-03-25 Add Technologies Ltd Advanced Drug Delivery Multipartikuläre Tabletten und Verfahren zur deren Herstellung
US8662705B2 (en) 2010-03-30 2014-03-04 Virwall Systems, Inc. Flexible ultraviolet LED sanitizing apparatus
WO2011135106A1 (es) * 2010-04-26 2011-11-03 Smart Pharma Solutions, S.L Granulado altamente dispersable para la preparación de formulaciones de sustancias activas de altas dosis y procedimiento de obtención del mismo
JP5750856B2 (ja) * 2010-10-04 2015-07-22 ライオン株式会社 固形医薬組成物及び医薬製剤
JP5974469B2 (ja) * 2010-12-24 2016-08-23 ライオン株式会社 錠剤の製造方法
WO2013095315A1 (en) * 2011-12-19 2013-06-27 Mahmut Bilgic Formulations comprising dexketoprofen (particle size 300-2500 micrometer)
EP2793853B1 (en) * 2011-12-23 2015-12-16 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Pharmaceutical formulations of flurbiprofen and glucosamin
EP2704696A1 (en) 2012-03-26 2014-03-12 Glatt AG Taste-masked ibuprofen granules
CN105050708A (zh) 2012-11-14 2015-11-11 格雷斯公司 含有生物活性材料与无序无机氧化物的组合物
EP2845850A1 (en) 2013-09-10 2015-03-11 ObsEva S.A. Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists
EP2886107A1 (en) 2013-12-17 2015-06-24 ObsEva S.A. Oral formulations of pyrrolydine derivatives
CZ20131023A3 (cs) * 2013-12-18 2014-08-27 Technická univerzita v Liberci Způsob rozvádění příze při jejím navíjení na cívku uloženou v navíjecím ústrojí pracovního místa textilního stroje a zařízení k jeho provádění
ES2774789T3 (es) 2014-07-02 2020-07-22 ObsEva SA O-Metiloxima de (3Z,5S)-5-(hidroximetil)-1-[(2'-metil-1,1'-bifenil-4-il)carbonil]pirrolidin-3-ona cristalina útil en métodos de tratamiento de estados relacionados con la actividad del OT-R
US20190022013A1 (en) * 2015-12-19 2019-01-24 First Time Us Generics Llc Soft-chew tablet pharmaceutical formulations
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
BE1023057B1 (nl) * 2016-06-06 2016-11-16 Nordic Specialty Pharma Bvba Ibuprofen tablet
JP6792235B2 (ja) * 2016-09-05 2020-11-25 株式会社アクロエッジ 凝集体の凝集度の測定方法及び凝集度測定装置

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56120616A (en) 1980-02-27 1981-09-22 Kaken Pharmaceut Co Ltd Ibuprofen-containing granule, its preparation, and internal medicine comprising it
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
US5240712A (en) * 1987-07-17 1993-08-31 The Boots Company Plc Therapeutic agents
SE463541B (sv) 1987-08-31 1990-12-10 Lejus Medical Ab Granulaer produkt oeverdragen av en smaelta av sig sjaelv samt foerfarande foer dess framstaellning
DE3833448A1 (de) * 1988-10-01 1990-04-12 Hoechst Ag Verfahren zur gewinnung von ibuprofen fuer die direkttablettierung
DK0524180T3 (da) 1990-04-11 1995-09-04 Upjohn Co Smagsmaskering af ibuprofen ved fluid bedovertrækning
CA2061520C (en) * 1991-03-27 2003-04-22 Lawrence J. Daher Delivery system for enhanced onset and increased potency
DK138592D0 (da) 1992-11-17 1992-11-17 Nycomed Dak As Tabletter
AT401871B (de) * 1994-01-28 1996-12-27 Gebro Broschek Gmbh Verfahren zur herstellung von s(+)-ibuprofen- partikeln mit verbesserten fliesseigenschaften und deren verwendung zur arzneimittelherstellung
US6068859A (en) * 1994-05-06 2000-05-30 Pfizer Inc. Controlled-release dosage forms of Azithromycin
DE4418837A1 (de) * 1994-05-30 1995-12-07 Bayer Ag Thermisches Granulierverfahren
GB9702392D0 (en) * 1997-02-06 1997-03-26 Boots Co Plc Therapeutic agents
DE19721467A1 (de) * 1997-05-22 1998-11-26 Basf Ag Verfahren zur Herstellung kleinteiliger Zubereitungen biologisch aktiver Stoffe
GB9710521D0 (en) 1997-05-22 1997-07-16 Boots Co Plc Process
CA2214895C (en) * 1997-09-19 1999-04-20 Bernard Charles Sherman Improved pharmaceutical composition comprising fenofibrate
IE980115A1 (en) * 1998-02-16 2000-02-09 Biovail Internat Ltd Solubilizing delivery systems and method of manufacture

Also Published As

Publication number Publication date
NO20022692D0 (no) 2002-06-06
SK285706B6 (sk) 2007-06-07
US20030203026A1 (en) 2003-10-30
HUP0203553A2 (hu) 2004-05-28
DE60027761T2 (de) 2007-01-25
SK8022002A3 (en) 2003-07-01
PT1235558E (pt) 2006-09-29
PL201223B1 (pl) 2009-03-31
AU3006001A (en) 2001-06-18
EP1235558B1 (en) 2006-05-03
CA2393585C (en) 2007-07-03
AR026917A1 (es) 2003-03-05
EP1235558A2 (en) 2002-09-04
CZ20021971A3 (cs) 2002-11-13
RU2246294C2 (ru) 2005-02-20
HUP0203553A3 (en) 2004-06-28
CY1106136T1 (el) 2011-06-08
WO2001041733A3 (en) 2001-11-15
US8124124B2 (en) 2012-02-28
ATE324868T1 (de) 2006-06-15
DE60027761D1 (de) 2006-06-08
MXPA02005663A (es) 2002-09-02
HK1046644A1 (en) 2003-01-24
BG106839A (bg) 2003-03-31
HK1046644B (en) 2006-11-10
AU2004231245A1 (en) 2004-12-23
IL150030A (en) 2008-06-05
NZ519485A (en) 2004-02-27
JP4040878B2 (ja) 2008-01-30
KR20020082464A (ko) 2002-10-31
PL355491A1 (en) 2004-05-04
NO332259B1 (no) 2012-08-13
NO20022692L (no) 2002-08-07
CA2393585A1 (en) 2001-06-14
AU776308B2 (en) 2004-09-02
IL150030A0 (en) 2002-12-01
ES2263510T3 (es) 2006-12-16
BG66007B1 (bg) 2010-10-29
HU227045B1 (en) 2010-05-28
WO2001041733A2 (en) 2001-06-14
CN1433300A (zh) 2003-07-30
CN100346774C (zh) 2007-11-07
JP2003516341A (ja) 2003-05-13
CZ300558B6 (cs) 2009-06-17
RU2002118210A (ru) 2004-02-20
BR0016236A (pt) 2002-12-24

Similar Documents

Publication Publication Date Title
DK1235558T3 (da) Sammenpresset tabletsammensætning, der omfatter et NSAID
DE60042781D1 (de) Beta2-adrenoceptor agonisten
FI991485L (fi) Uusi farmaseuttinen koostumus
NO20021449D0 (no) Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og anvendelse derav
NO20015175L (no) Farmasöytisk sammensetning
DE60230216D1 (de) Kaskodenkettenverstärker
FI19992171A7 (fi) Sprinkleri
PT1086701E (pt) Composicao laxante contendo simeticone
DE60014955D1 (de) Schraubzange
NO20041195L (no) Tablettmater.
NO990431D0 (no) Golfk°llehode
DE60016868D1 (de) Notrutsche
DE69925167D1 (de) Hochwitterungsbeständige pulverlackzusammensetzung
BR0008833B1 (pt) Êmbolo construÍdo.
NO20022606L (no) Farmasöytiske kombinasjoner
IT248273Y1 (it) Motozappa portatile.
FR2833599B1 (fr) Polysaccharide amphotere, composition et utilisation
MA25359A1 (fr) Composition agrochimique.
FI4488U1 (fi) Farmaseuttinen koostumus
ID30056A (id) Agonis-agonis 5-htif
DE50010260D1 (de) Rundläufer-Tablettenpresse
NO20022845L (no) Limsammensetning
NO991359D0 (no) Tablettdispenser
ES1046480Y (es) Mantel perfeccionado.
FI4077U1 (fi) Pellettipuristin